However, TJ-M2010-2 incubation reversed the effects of TGF-β1. Therefore, TJ-M2010-2 ameliorates renal fibrosis by decreasing TGF-β1 levels and inhibiting EMT. Here, TGFB1 is linked to renal fibrosis.